|

Atomoxetine Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • University College, London1
  • Radboud University Medical Center1
  • Icahn School of Medicine at Mount Sinai1

Indications

  • MCOS1
  • Melanocortin Obesity Syndrome1
  • Alzheimer Disease Dementia1
  • Freezing of Gait Symptoms in Parkinson Disease1
  • Freezing of Gait1

Other2 trials

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
Phase 3
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
Phase 3

New York, New York1 trial

Atomoxetine in Melanocortin Obesity Syndrome

Mount Sinai Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.